scientific Sessions

Cancer Genomics and Epigenomics

This session highlights the intersection of genomic and epigenomic changes in cancer. It explores how mutations, copy number variations, and epigenetic modifications, such as DNA methylation and histone modifications, contribute to tumorigenesis. At the Cancer Research and Development Conference 2025, experts will discuss how next-generation sequencing and epigenetic profiling advances are enabling more precise cancer diagnostics and targeted therapies. The session will also address the role of cancer genome atlas data in identifying key biomarkers for personalized treatment strategies.

Related Sessions

Advances in Nanotechnology for Cancer Treatment
Cellular Therapies Beyond CAR-T
The Role of Epigenetics in Cancer Diagnosis
Cancer Genomics and Epigenomics
Liquid Biopsy Innovations
Immunomodulatory Molecules in Cancer Therapy
Pediatric Oncology
Advances in Cancer Genetics and Genomics
Novel Cancer Vaccines
Systems Biology in Cancer Research
Cutting-Edge Therapies in Cancer Treatment
Tumour Suppressor Molecules in Cancer Therapy
Molecular Imaging Agents for Cancer
Organoids and 3D Bioprinting in Cancer R&D
Don't miss our future updates!

Get in Touch